Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers.

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Oncology

Background:

• Icariside II is a flavonoid from Epimedium with anti-inflammatory, anticancer, and anti-osteoporotic properties.
• Apoptosis induction is a key strategy in modern cancer therapy.
• Icariside II demonstrates antitumorigenic effects via cell cycle arrest, autophagy, and reduced metabolism.

Purpose of the Study:

• To review the chemopreventive properties of Icariside II in solid tumors.
• To elucidate the molecular mechanisms underlying Icariside II's anticancer activity.
• To highlight Icariside II's potential as a natural chemopreventive agent.

Main Methods:

• Literature review of studies on Icariside II and its anticancer effects.
• Analysis of molecular pathways involved in Icariside II-mediated apoptosis and proliferation inhibition.
• Examination of Icariside II's synergistic effects with chemotherapy.

Main Results:

• Icariside II inhibits proliferation, metastasis, and angiogenesis in various cancers.
• It induces apoptosis and cell cycle arrest, showing broad antitumorigenic activity.
• Icariside II exhibits synergistic effects with conventional chemotherapeutic drugs.

Conclusions:

• Icariside II is a promising natural compound for solid tumor chemoprevention.
• Its therapeutic efficacy is mediated through multiple molecular mechanisms.
• Strategies to improve Icariside II's solubility and permeability are crucial for clinical application.